Yasuhiro Fujii

Dr. Yasuhiro Fujii

Cardiovascular Surgery, Okayama University Hospital, Okayama, Japan
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
YFYasuhiro Fujii
Yasuhiro Fujii
SSShunji Sano
Shunji Sano
TAToshihide Asou
Toshihide Asou
YIYutaka Imoto
Yutaka Imoto
YOYoshihiro Oshima
Yoshihiro Oshima
KMKozo Matsuo
Kozo Matsuo

1 July 2015 in ASAIO Journal
Verified
Journal Article
Closed access
YFYasuhiro Fujii
Yasuhiro Fujii
GFGiuseppe Ferro
Giuseppe Ferro
HKHiroshi Kagawa
Hiroshi Kagawa
LCLuca Centola
Luca Centola
LZLiqun Zhu
Liqun Zhu
OROlaf Reinhartz
Olaf Reinhartz
Durable mechanical support in situations of physiologic single ventricle has been met with little success so far, particularly in small children. We created an animal model to investigate whether pulsatile or continuous flow would be superior. Three 1 month old sheep (10-16 kg) were instrumented. Via sternotomy and with cardiopulmonary bypass, a large ventricular septal defect and atrial septal defect were created. The left ventricle was cannulated using a Berlin Heart inflow cannula. This was connected sequentially to a continuous flow device (Thoratec HeartMate X, Pleasanton, CA) and to a pulsatile device (Berlin Heart Excor, The Woodlands, TX). Outflow was via a Y-graft to both aorta and pulmonary artery, striving for equal flow to both. Atrial filling pressures were controlled with volume infusions over a wide range. Under comparable loading conditions, significantly higher maximum flow was obtained by HeartMate X than by Excor (4.95 ± 1.27 L/min [range, 3.84-6.34 L/min] for HeartMate X vs. 1.80 ± 0.85 L/min [range, 1.01-2.7 L/min] for Excor; p < 0.05). Judging from this limited animal study, in single ventricle scenarios, continuous flow devices may achieve higher pump flows than pulsatile devices when provided with similar filling pressures. Their clinical use should be investigated. More extensive experimental studies are needed.

1 November 2011 in Artificial Organs
Verified
Journal Article
Closed access
PDF file
YFYasuhiro Fujii
Yasuhiro Fujii
KIKozo Ishino
Kozo Ishino
TTTomoko Tomii
Tomoko Tomii
HKHitoshi Kanamitsu
Hitoshi Kanamitsu
YFYasufumi Fujita
Yasufumi Fujita
SSShunji Sano
Shunji Sano

1 October 2009
Verified
Journal Article
Closed access
YFYasufumi Fujita
Yasufumi Fujita
KIKozo Ishino
Kozo Ishino
KNKoji Nakanishi
Koji Nakanishi
YFYasuhiro Fujii
Yasuhiro Fujii
MKMasaaki Kawada
Masaaki Kawada
SSShunji Sano
Shunji Sano

1 May 2015 in ASAIO Journal
Verified
Journal Article
Closed access
YFYasuhiro Fujii
Yasuhiro Fujii
KPKoullis Pitsillides
Koullis Pitsillides
GFGiuseppe Ferro
Giuseppe Ferro
HKHiroshi Kagawa
Hiroshi Kagawa
LCLuca Centola
Luca Centola
OROlaf Reinhartz
Olaf Reinhartz
Telemetric physiological monitoring systems (TPMS) have enabled accurate continuous measurement of animal blood pressures and flows. However, few studies describe approaches for use of TPMS in the great vessels or inside the heart. We describe our initial experiences using two types of TPMSs. Twelve lambs (20–37 kg) underwent sternotomy. Two lambs were not instrumented and were killed at 14 days to confirm normal sternal wound healing (sham group, n = 2). Ten lambs underwent placement of either standard indwelling pressure-monitoring catheter and perivascular-flow-probe (CFP group, n = 3) or TPMS implantation (TPMS group, n = 7). The TPMS used were EG1-V3S2T-M2 (EG1, n = 5; Transonic Endogear Inc.) and Physio Tel Digital L21 (PTD, n = 2; Data Sciences Inc.). Two deaths because of respiratory problems occurred in TPMS group, attributed to lung compression by the implanted device. In TPMS group, more consistent trends of blood pressures and flows were recorded, and management of animals was easier and less labor-intensive. Comparing the two TPMSs, the initiation and renewal costs for each case was $28 K vs. $20 K and $1,700 vs. $0, (PTD versus EG1, respectively). In conclusion, TPMS implantation was feasible via median sternotomy in lambs. Telemetric physiological monitoring systems significantly improve reliability of hemodynamic monitoring in chronic survival animal study. EG1 was less costly than PTD.

4 July 2013 in Artificial Organs
Verified
Journal Article
Closed access
PDF file
HKHitoshi Kanamitsu
Hitoshi Kanamitsu
YFYasuhiro Fujii
Yasuhiro Fujii
HMHideya Mitsui
Hideya Mitsui
SSShunji Sano
Shunji Sano